An antiviral innate immune response involves induction of type I interferons (IFNs) and their subsequent autocrine and paracrine actions, but the underlying regulatory mechanisms are incompletely understood. Here we report that CYLD, a deubiquitinase that specifically digests lysine 63-linked ubiquitin chains, is required for antiviral host defense. Loss of CYLD renders mice considerably more susceptible to infection by vesicular stomatitis virus (VSV). Consistently, CYLD-deficient dendritic cells are more sensitive to VSV infection. This functional defect was not due to lack of type I IFN production but rather because of attenuated IFN receptor signaling. In the absence of CYLD, IFN-b is ineffective in the induction of antiviral genes and protection of cells from viral infection. These findings establish CYLD as a novel regulator of antiviral innate immunity and suggest a role for CYLD in regulating IFN receptor signaling.
INTRODUCTION
Innate immunity serves as the first line of host defense against microbial infections. Development of antiviral innate immunity involves induction of type I interferons (IFNs), which is triggered when host pattern recognition receptors detect viral products.
1 Once produced by virusinfected cells, IFNs bind to their receptor, the type I IFN-a/-b receptor (IFNAR), to elicit a second wave of signaling events; these include activation of Janus kinases and subsequent phosphorylation of their target transcription factors, signal transducer and activator of transcription 1 (STAT1) and STAT2. 2 Phosphorylated STATs form dimers and migrate into the nucleus to participate in transactivation of IFNresponsive genes involved in the establishment of an antiviral state. 2 An important antiviral signaling pathway is mediated by the intracellular pattern recognition receptor RIG-I, which detects viral RNA in the cytoplasm and activates the protein kinases, tank-binding kinase-1 (TBK1) and IkB kinase-e (IKKe). TBK1 and IKKe in turn induce IFN gene expression by activating transcription factors, IFN regulatory factor 3 (IRF3) and IRF7. 3 The activation of RIG-I involves its conjugation or binding of lysine 63 (K63)-linked polyubiquitin chains. 4, 5 We and others have recently shown that RIG-I ubiquitination and TBK1/IKKe activation are negatively regulated by CYLD, 6,7 a deubiquitinase known to digest K63-linked ubiquitin chains. 8 In the present study, we examined the role of CYLD in antiviral innate immunity using the vesicular stomatitis virus (VSV) model, which is known to stimulate the RIG-I pathway. 3 To our surprise, despite its negative role in TBK1/IKKe activation, 6, 7 CYLD has a positive function in mediating anti-VSV immunity. CYLD deficiency attenuates antiviral host defense both in animals and in cell culture. Our findings thus establish CYLD as a novel and critical regulator of antiviral innate immune responses.
MATERIALS AND METHODS

Mice
Cyld knockout mice were generated as described previously. 9 Heterozygous (Cyld 1/-) mice were intercrossed to generate Cyld -/-and Cyld 1/1 littermates. 10 Mice were housed in specific pathogen-free cages, and experiments were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of Texas MD Anderson Cancer Center.
Antibodies and reagents
Antibodies for STAT1 (B-9) and Tubulin (TU-02) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Antiphospho-STAT1 (Tyr701) and anti-VSV-G were from Cell Signaling (Danvers, MA, USA) and Sigma-Aldrich (St Louis, MO, USA), respectively. The CYLD antibody was as described previously.
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Recombinant IFN-b was purchased from PeproTech (Rocky Hill, NJ, USA).
Viruses and infection VSV (Indiana strain) was provided by Glen Barber. 12 Infection of bone marrow-derived dendritic cells (DCs) was as described. 7 For in vivo infection, age-matched CYLD 1/1 and CYLD -/-mice were infected intravenously (i.v.) via tail veins or intranasally (i.n.) by placing a droplet between the nostrils using a pipettor. The infected mice were observed daily for disease symptoms and mortality. Animals displaying hindlimb paralysis or severe morbidity were noted as such and euthanized according to the Institutional Animal Care and Use Committee protocol.
Real-time quantitative PCR with reverse transcription RNA preparation and real-time quantitative PCR were as described. 7 The gene-specific primer sets (all for murine genes) were: Mx1, 59-AAACCTGATCCGACTTCACTTCC-39 and 59-TGATCGTCTTCA-AGGTTTCCTTGT-39;Author: is it ok to add '-39' here? Ifi203, 59-CTC-TCACTGATGGTAAGACTTAC-39 and 59-CTGCAGGTACATGGTC-AGTCAC-39; Adar1, 59-GTGAGTTTCGAGCCATCATGG-39 and 59-TTCAGCTGGCACTCAGTTAGC-39; Actin, 59-CGTGAAAAGAT-GACCCAGATCA-39 and 59-CACAGCCTGGATGGCTACGT-39.
Immunoblotting (IB)
Whole-cell lysates were prepared in a kinase cell lysis buffer supplemented with phosphatase inhibitors and subjected to IB as previously described. 13 RESULTS AND DISCUSSION CYLD is required for host defense against VSV infection Since CYLD negatively regulates IFN induction, 6, 7 we examined whether the loss of CYLD renders mice more resistant to viral infection. Age-matched CYLD 1/1 and CYLD -/-mice were infected i.v. with a sublethal dose of VSV and monitored daily for mortality and survival over a course of 14 days. Under these conditions, about 60% of the CYLD 1/1 mice survived the infection (Figure 1a) . Surprisingly, the CYLD -/-mice did not show enhanced antiviral ability. In fact, the CYLD -/-mice were substantially more sensitive to VSV infection, with only about 20% of the mice surviving under the same conditions (Figure 1a) .
To examine whether the role of CYLD in antiviral defense is routedependent, we repeated the experiment with i.n. infections. We selected a dose range known to cause a low level of mortality in wild-type mice.
14,15 At a dose of 2.5310 4 plaque-forming unit, more than 80% of the CYLD 1/1 mice survived the infection following a 12-day period of observation ( Figure 1b ). As seen with the i.v. injection, the CYLD -/-mice had a much higher mortality rate, with only about 20% surviving the infection (Figure 1b) . The mice that eventually died of the infection also displayed notable disease symptoms during early phase, including respiratory distress, piloerection, disorientation and other neurological symptoms. These results reveal a novel and unexpected function of CYLD in regulating antiviral host defense.
To examine whether the CYLD -/-cells are intrinsically more sensitive to VSV infection, we infected wild-type and CYLD -/-DCs with VSV and assessed the efficiency of viral infection based on the expression of a major viral glycoprotein, VSV-G. Consistent with the wholeanimal studies, the CYLD -/-DCs were considerably more sensitive to VSV infection compared to the CYLD 1/1 DCs (Figure 1c) . These results further establish the crucial role for CYLD in regulating antiviral innate immunity.
CYLD deficiency attenuates IFN-induced antiviral defense and signaling
Since loss of CYLD does not block, but rather promotes, the induction of IFNs, 7 the question was raised as to how the CYLD deficiency attenuates antiviral host defense. As stated above, antiviral innate immunity involves both the initial induction of type I IFNs and the subsequent effector functions of IFNs. When secreted by virusinfected cells, type I IFNs bind to their specific receptor, IFNAR, on both the infected cells and neighboring uninfected cells. Thus, IFNs not only restrain the replication of viruses in infected cells but also protect uninfected cells from viral infection. To further address the mechanism by which CYLD regulates antiviral innate immunity, we examined how CYLD deficiency affects cellular responses to IFNs. We used a well-defined method to compare the IFN responses of CYLD 1/1 and CYLD -/-DCs. When pre-incubated with exogenous IFN-b, wild-type cells were efficiently protected from VSV infection (Figure 2a) . In contrast, IFN-b was considerably less efficient in protecting the CYLD -/-cells, generating a notable protective effect only at a very high concentration (100 unit/ml, Figure 2a ). This finding indicates that CYLD may control the efficiency of IFN-induced cell signaling.
A critical step in IFN-induced cell signaling is tyrosine phosphorylation of STAT1, which serves as a molecular trigger for its dimerization and nuclear translocation. 2 As expected, IFN-b induced rapid and sustained STAT1 phosphorylation in wild-type DCs (Figure 2b) . 1/1 and CYLD -/-DCs were either mock-infected or infected with the indicated moi of VSV for 20 h. The level of VSV infection was assessed by IB to detect a major VSV glycoprotein, VSV-G. Tubulin IB was used as a loading control. DC, dendritic cell; IB, immunoblotting; i.n., intranasally; i.v., intravenously; moi, multiplicity of infection; PFU, plaqueforming unit; VSV, vesicular stomatitis virus.
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Consistent with the antiviral functional assays described above, the CYLD deficiency significantly attenuated, although it did not block, the inducible phosphorylation of STAT1 (Figure 2b ). The consequence of IFN signaling is the induction of genes involved in the establishment of an antiviral state. We thus examined how the loss of CYLD affected IFN-induced gene expression. Stimulation of wild-type DCs with IFN-b led to strong induction of three known IFN-responsive genes, 16 Mx1, Adar1 and Ifi203 (Figure 2c ). Remarkably, the induction of all three of these genes was diminished in CYLD -/-DCs (Figure 2c ). Thus, CYLD is a crucial factor that mediates effective IFN signaling and antiviral gene induction.
In conclusion, the results presented in this paper establish CYLD as a novel mediator of antiviral innate immune responses. These findings were unexpected since CYLD is generally considered to be a negative signaling factor. Our findings are consistent with a prior report that genetic deficiency in the Drosophila CYLD homologue renders flies more vulnerable to infections. 17 Although it remains unclear how CYLD regulates host defense in Drosophila, our present study suggests a role for mammalian CYLD in controlling IFN receptor signaling. Given the important role of ubiquitination in the regulation of IFNAR1 function, 18 it is plausible that CYLD may directly act on IFNAR1 by modulating its ubiquitination. Future studies will examine this intriguing possibility. Regulation of antiviral innate immunity by CYLD MY Zhang et al 504
